BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 36931287)

  • 1. Machine learning-based automated sponge cytology for screening of oesophageal squamous cell carcinoma and adenocarcinoma of the oesophagogastric junction: a nationwide, multicohort, prospective study.
    Gao Y; Xin L; Lin H; Yao B; Zhang T; Zhou AJ; Huang S; Wang JH; Feng YD; Yao SH; Guo Y; Dang T; Meng XM; Yang ZZ; Jia WQ; Pang HF; Tian XJ; Deng B; Wang JP; Fan WC; Wang J; Shi LH; Yang GY; Sun C; Wang W; Zang JC; Li SY; Shi RH; Li ZS; Wang LW
    Lancet Gastroenterol Hepatol; 2023 May; 8(5):432-445. PubMed ID: 36931287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility and Accuracy of Artificial Intelligence-Assisted Sponge Cytology for Community-Based Esophageal Squamous Cell Carcinoma Screening in China.
    Gao Y; Xin L; Feng YD; Yao B; Lin H; Sun C; An W; Li ZS; Shi RH; Wang LW
    Am J Gastroenterol; 2021 Nov; 116(11):2207-2215. PubMed ID: 34546186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection of high-risk individuals for esophageal cancer screening: A prediction model of esophageal squamous cell carcinoma based on a multicenter screening cohort in rural China.
    Chen W; Li H; Ren J; Zheng R; Shi J; Li J; Cao M; Sun D; He S; Sun X; Cao X; Feng S; Zhou J; Luo P; Zha Z; Jia S; Wang J; Ma H; Zeng H; Canfell K; He J
    Int J Cancer; 2021 Jan; 148(2):329-339. PubMed ID: 32663318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artificial intelligence for tumour tissue detection and histological regression grading in oesophageal adenocarcinomas: a retrospective algorithm development and validation study.
    Tolkach Y; Wolgast LM; Damanakis A; Pryalukhin A; Schallenberg S; Hulla W; Eich ML; Schroeder W; Mukhopadhyay A; Fuchs M; Klein S; Bruns C; Büttner R; Gebauer F; Schömig-Markiefka B; Quaas A
    Lancet Digit Health; 2023 May; 5(5):e265-e275. PubMed ID: 37100542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Model To Identify Individuals at High Risk for Esophageal Squamous Cell Carcinoma and Precancerous Lesions in Regions of High Prevalence in China.
    Liu M; Liu Z; Cai H; Guo C; Li X; Zhang C; Wang H; Hang D; Liu F; Deng Q; Yang X; Yuan W; Pan Y; Li J; Zhang C; Shen N; He Z; Ke Y
    Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1538-1546.e7. PubMed ID: 28342951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study protocol for artificial intelligence-assisted sponge cytology as pre-endoscopy screening for early esophegeal squmaous epithelial lesions in China.
    Feng Y; Wang B; Pan L; Yao B; Deng B; Liang Y; Sun Y; Zang J; Xu X; Song J; Li M; Xu G; Zhao K; Cheng CE; Shi R
    BMC Cancer; 2022 Oct; 22(1):1105. PubMed ID: 36307758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved esophageal squamous cell carcinoma screening effectiveness by risk-stratified endoscopic screening: evidence from high-risk areas in China.
    Li H; Ding C; Zeng H; Zheng R; Cao M; Ren J; Shi J; Sun D; He S; Yang Z; Yu Y; Zhang Z; Sun X; Guo G; Song G; Wei W; Chen W; He J
    Cancer Commun (Lond); 2021 Aug; 41(8):715-725. PubMed ID: 34146456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of an artificial intelligence-assisted system on endoscopic diagnosis of superficial oesophageal squamous cell carcinoma and precancerous lesions: a multicentre, tandem, double-blind, randomised controlled trial.
    Yuan XL; Liu W; Lin YX; Deng QY; Gao YP; Wan L; Zhang B; Zhang T; Zhang WH; Bi XG; Yang GD; Zhu BH; Zhang F; Qin XB; Pan F; Zeng XH; Chaudhry H; Pang MY; Yang J; Zhang JY; Hu B
    Lancet Gastroenterol Hepatol; 2024 Jan; 9(1):34-44. PubMed ID: 37952555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Artificial intelligence assisted cytological detection for early esophageal squamous epithelial lesions by using low-grade squamous intraepithelial lesion as diagnostic threshold.
    Yao B; Feng Y; Zhao K; Liang Y; Huang P; Zang J; Song J; Li M; Wang X; Shu H; Shi R
    Cancer Med; 2023 Jan; 12(2):1228-1236. PubMed ID: 35766144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and Validation of Esophageal Squamous Cell Carcinoma Risk Prediction Models Based on an Endoscopic Screening Program.
    Han J; Guo X; Zhao L; Zhang H; Ma S; Li Y; Zhao D; Wang J; Xue F
    JAMA Netw Open; 2023 Jan; 6(1):e2253148. PubMed ID: 36701154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibodies: Potential clinical applications in early detection of esophageal squamous cell carcinoma and esophagogastric junction adenocarcinoma.
    Xu YW; Peng YH; Xu LY; Xie JJ; Li EM
    World J Gastroenterol; 2019 Sep; 25(34):5049-5068. PubMed ID: 31558856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oesophagectomy for carcinoma of the oesophagus and oesophagogastric junction.
    Dalrymple-Hay MJ; Evans KB; Lea RE
    Eur J Cardiothorac Surg; 1999 May; 15(5):626-30. PubMed ID: 10386408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum DSG2 as a potential biomarker for diagnosis of esophageal squamous cell carcinoma and esophagogastric junction adenocarcinoma.
    Liu YQ; Chu LY; Yang T; Zhang B; Zheng ZT; Xie JJ; Xu YW; Fang WK
    Biosci Rep; 2022 May; 42(5):. PubMed ID: 35521959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carditis, intestinal metaplasia and adenocarcinoma of oesophagogastric junction.
    Conio M; Filiberti R; Blanchi S; Giacosa A
    Eur J Cancer Prev; 2001 Dec; 10(6):483-7. PubMed ID: 11916346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of oesophagectomy for adenocarcinoma of the oesophagus and oesophagogastric junction.
    Zhang X; Watson DI; Jamieson GG; Lally C; Bessell JR; Devitt PG
    ANZ J Surg; 2005 Jul; 75(7):513-9. PubMed ID: 15972033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-time artificial intelligence for detection of upper gastrointestinal cancer by endoscopy: a multicentre, case-control, diagnostic study.
    Luo H; Xu G; Li C; He L; Luo L; Wang Z; Jing B; Deng Y; Jin Y; Li Y; Li B; Tan W; He C; Seeruttun SR; Wu Q; Huang J; Huang DW; Chen B; Lin SB; Chen QM; Yuan CM; Chen HX; Pu HY; Zhou F; He Y; Xu RH
    Lancet Oncol; 2019 Dec; 20(12):1645-1654. PubMed ID: 31591062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ramucirumab plus pembrolizumab in patients with previously treated advanced non-small-cell lung cancer, gastro-oesophageal cancer, or urothelial carcinomas (JVDF): a multicohort, non-randomised, open-label, phase 1a/b trial.
    Herbst RS; Arkenau HT; Santana-Davila R; Calvo E; Paz-Ares L; Cassier PA; Bendell J; Penel N; Krebs MG; Martin-Liberal J; Isambert N; Soriano A; Wermke M; Cultrera J; Gao L; Widau RC; Mi G; Jin J; Ferry D; Fuchs CS; Petrylak DP; Chau I
    Lancet Oncol; 2019 Aug; 20(8):1109-1123. PubMed ID: 31301962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Incidence and pathologic distribution of esophageal cancers at the gastro-esophageal junction between 1993-2003].
    Lakatos PL; Lakatos L; Fuszek P; Lukovich P; Kupcsulik P; Halbász J; Schaff Z; Papp J
    Orv Hetil; 2005 Feb; 146(9):411-6. PubMed ID: 15830608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Rapid Cytological Screening as pre-Endoscopy Screening for Early Esophageal Squamous Cell Lesions: A Prospective Pilot Study from a Chinese Academic Center.
    Feng Y; Liang Y; Yao B; Xu J; Zang J; Zhang Y; Zhang J; Xu G; Wei B; Yao X; Huang P; Shi R
    Technol Cancer Res Treat; 2022; 21():15330338211066200. PubMed ID: 35040718
    [No Abstract]   [Full Text] [Related]  

  • 20. Pooled analysis of the performance of liquid-based cytology in population-based cervical cancer screening studies in China.
    Pan QJ; Hu SY; Zhang X; Ci PW; Zhang WH; Guo HQ; Cao J; Zhao FH; Lytwyn A; Qiao YL
    Cancer Cytopathol; 2013 Sep; 121(9):473-82. PubMed ID: 23907807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.